Ridiculous Study of the Week: Weight Loss Helps Overweight People

You are not going to believe this but weight loss benefits overweight people with diabetes.  Yup, it’s true:

For overweight, but not obese, individuals with type 2 diabetes (T2D), sustained weight loss (WL) of 10 percent body weight is associated with clinically meaningful cardiometabolic changes, according to research published online Feb. 19 in Diabetes Care.

You can now sleep better at night knowing there are researchers out there who are breaking barriers and thinking outside the box.

Douglas Farrago MD

Douglas Farrago MD is a full-time practicing family doc in Forest, Va. He started Forest Direct Primary Care where he takes no insurance and bills patients a monthly fee. He is board certified in the specialty of Family Practice. He is the inventor of a product called the Knee Saver which is currently in the Baseball Hall of Fame. The Knee Saver and its knock-offs are worn by many major league baseball catchers. He is also the inventor of the CryoHelmet used by athletes for head injuries as well as migraine sufferers. Dr. Farrago is the author of four books, two of which are the top two most popular DPC books. From 2001 – 2011, Dr. Farrago was the editor and creator of the Placebo Journal which ran for 10 full years. Described as the Mad Magazine for doctors, he and the Placebo Journal were featured in the Washington Post, US News and World Report, the AP, and the NY Times. Dr. Farrago is also the editor of the blog Authentic Medicine which was born out of concern about where the direction of healthcare is heading and the belief that the wrong people are in charge. This blog has been going daily for more than 15 years Article about Dr. Farrago in Doximity Email Dr. Farrago – [email protected] 

  1 comment for “Ridiculous Study of the Week: Weight Loss Helps Overweight People

  1. HJR
    February 25, 2017 at 12:49 pm

    Just about as helpful as the studies that show increased rates of depression in patients with some terminal disorder.

Comments are closed.